| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteroides fragilis | 33 | 2024 | 46 | 8.790 |
Why?
|
| Bacteroides | 21 | 2024 | 35 | 5.650 |
Why?
|
| Symbiosis | 16 | 2024 | 131 | 4.340 |
Why?
|
| Bacterial Proteins | 34 | 2024 | 907 | 4.130 |
Why?
|
| Gastrointestinal Microbiome | 19 | 2024 | 556 | 4.040 |
Why?
|
| Bacteroidetes | 13 | 2024 | 39 | 3.650 |
Why?
|
| Type VI Secretion Systems | 9 | 2024 | 9 | 3.330 |
Why?
|
| Bacterial Capsules | 19 | 2024 | 29 | 3.230 |
Why?
|
| Intestines | 13 | 2016 | 424 | 3.120 |
Why?
|
| Polysaccharides | 11 | 2021 | 93 | 2.520 |
Why?
|
| Anti-Infective Agents | 4 | 2022 | 91 | 2.240 |
Why?
|
| Polysaccharides, Bacterial | 10 | 2011 | 33 | 2.040 |
Why?
|
| DNA, Bacterial | 9 | 2024 | 247 | 1.990 |
Why?
|
| Gastrointestinal Tract | 9 | 2024 | 192 | 1.880 |
Why?
|
| Gene Transfer, Horizontal | 5 | 2024 | 39 | 1.840 |
Why?
|
| Bacteria | 7 | 2024 | 501 | 1.770 |
Why?
|
| Glycoproteins | 7 | 2013 | 234 | 1.560 |
Why?
|
| Genome, Bacterial | 6 | 2024 | 152 | 1.480 |
Why?
|
| Antibiosis | 4 | 2020 | 9 | 1.430 |
Why?
|
| Gene Expression Regulation, Bacterial | 10 | 2024 | 219 | 1.420 |
Why?
|
| Bacterial Toxins | 5 | 2024 | 115 | 1.350 |
Why?
|
| Interspersed Repetitive Sequences | 4 | 2024 | 12 | 1.270 |
Why?
|
| Anti-Bacterial Agents | 7 | 2024 | 810 | 1.040 |
Why?
|
| Bacteriocins | 3 | 2021 | 12 | 0.980 |
Why?
|
| Feces | 10 | 2024 | 349 | 0.890 |
Why?
|
| Promoter Regions, Genetic | 12 | 2024 | 968 | 0.850 |
Why?
|
| Genes, Bacterial | 8 | 2016 | 199 | 0.740 |
Why?
|
| Colon | 4 | 2019 | 527 | 0.720 |
Why?
|
| Bacteroides Infections | 4 | 2016 | 8 | 0.710 |
Why?
|
| Fucose | 2 | 2014 | 13 | 0.700 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2020 | 4 | 0.670 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 301 | 0.650 |
Why?
|
| Genetic Engineering | 1 | 2019 | 117 | 0.620 |
Why?
|
| Microbial Interactions | 1 | 2018 | 11 | 0.610 |
Why?
|
| Phylogeny | 1 | 2024 | 1228 | 0.610 |
Why?
|
| Humans | 57 | 2024 | 92337 | 0.600 |
Why?
|
| Glycosylation | 5 | 2021 | 133 | 0.590 |
Why?
|
| Recombinases | 3 | 2007 | 21 | 0.560 |
Why?
|
| Colitis | 2 | 2024 | 252 | 0.560 |
Why?
|
| Chromosome Inversion | 4 | 2007 | 47 | 0.560 |
Why?
|
| Ubiquitin | 1 | 2017 | 96 | 0.540 |
Why?
|
| Microbiota | 3 | 2021 | 412 | 0.540 |
Why?
|
| Metagenome | 2 | 2024 | 109 | 0.530 |
Why?
|
| Vibrio cholerae | 7 | 2020 | 17 | 0.520 |
Why?
|
| Fimbriae Proteins | 1 | 2016 | 15 | 0.510 |
Why?
|
| Fimbriae, Bacterial | 1 | 2016 | 24 | 0.510 |
Why?
|
| Molecular Sequence Data | 14 | 2014 | 3017 | 0.510 |
Why?
|
| RNA, Bacterial | 1 | 2016 | 111 | 0.500 |
Why?
|
| O Antigens | 4 | 2007 | 12 | 0.490 |
Why?
|
| Sulfatases | 1 | 2015 | 3 | 0.490 |
Why?
|
| RNA Interference | 1 | 2016 | 384 | 0.480 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 2006 | 32 | 0.480 |
Why?
|
| Secretory Vesicles | 1 | 2015 | 43 | 0.470 |
Why?
|
| Antigens, Bacterial | 2 | 2015 | 136 | 0.460 |
Why?
|
| Animals | 27 | 2024 | 28003 | 0.440 |
Why?
|
| Conserved Sequence | 2 | 2013 | 211 | 0.430 |
Why?
|
| Disease | 1 | 2014 | 92 | 0.430 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2021 | 55 | 0.430 |
Why?
|
| Epithelium | 1 | 2014 | 324 | 0.430 |
Why?
|
| Mice | 18 | 2024 | 12110 | 0.420 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 239 | 0.410 |
Why?
|
| Computational Biology | 3 | 2011 | 566 | 0.400 |
Why?
|
| Intestine, Small | 1 | 2014 | 301 | 0.400 |
Why?
|
| Plasmids | 2 | 2024 | 288 | 0.400 |
Why?
|
| Biological Evolution | 2 | 2020 | 992 | 0.390 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2014 | 281 | 0.390 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2024 | 611 | 0.390 |
Why?
|
| Intestinal Mucosa | 4 | 2013 | 814 | 0.380 |
Why?
|
| Carboxy-Lyases | 1 | 2011 | 22 | 0.370 |
Why?
|
| Bacterial Infections | 2 | 2018 | 185 | 0.370 |
Why?
|
| Immunoglobulin A | 2 | 2011 | 87 | 0.360 |
Why?
|
| Conjugation, Genetic | 2 | 2024 | 23 | 0.350 |
Why?
|
| Complement Membrane Attack Complex | 2 | 2024 | 21 | 0.340 |
Why?
|
| Amino Acid Sequence | 7 | 2021 | 2074 | 0.330 |
Why?
|
| Proteome | 1 | 2010 | 149 | 0.320 |
Why?
|
| Transcription Factors | 2 | 2024 | 1684 | 0.320 |
Why?
|
| Germ-Free Life | 4 | 2020 | 79 | 0.310 |
Why?
|
| Base Sequence | 8 | 2019 | 2317 | 0.310 |
Why?
|
| Endothelium, Vascular | 5 | 1995 | 437 | 0.300 |
Why?
|
| Microbial Viability | 2 | 2024 | 33 | 0.300 |
Why?
|
| Inulin | 2 | 2019 | 17 | 0.290 |
Why?
|
| Operon | 2 | 2024 | 50 | 0.290 |
Why?
|
| Evolution, Molecular | 3 | 2024 | 863 | 0.290 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 2004 | 0.270 |
Why?
|
| Mammals | 1 | 2008 | 245 | 0.260 |
Why?
|
| Mutation | 8 | 2020 | 4204 | 0.250 |
Why?
|
| Genetic Variation | 2 | 2024 | 1392 | 0.250 |
Why?
|
| Gene Deletion | 3 | 2017 | 351 | 0.250 |
Why?
|
| Chromosome Mapping | 4 | 2003 | 1076 | 0.240 |
Why?
|
| Genetic Fitness | 1 | 2024 | 39 | 0.230 |
Why?
|
| Tyrosine | 1 | 2004 | 133 | 0.220 |
Why?
|
| Metabolomics | 1 | 2024 | 95 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 874 | 0.220 |
Why?
|
| Succinate Dehydrogenase | 1 | 2022 | 16 | 0.210 |
Why?
|
| Bacterial Adhesion | 3 | 1993 | 85 | 0.200 |
Why?
|
| Membrane Proteins | 2 | 2010 | 1240 | 0.200 |
Why?
|
| Carbohydrate Dehydrogenases | 2 | 1999 | 4 | 0.200 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2021 | 77 | 0.200 |
Why?
|
| Borrelia burgdorferi Group | 2 | 1993 | 4 | 0.190 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 9 | 0.190 |
Why?
|
| Diet | 2 | 2020 | 448 | 0.190 |
Why?
|
| Models, Biological | 3 | 2020 | 1786 | 0.180 |
Why?
|
| Genomics | 2 | 2024 | 806 | 0.180 |
Why?
|
| DNA Restriction-Modification Enzymes | 1 | 2020 | 2 | 0.180 |
Why?
|
| Metagenomics | 2 | 2019 | 95 | 0.170 |
Why?
|
| Ecosystem | 3 | 2021 | 371 | 0.170 |
Why?
|
| Ribose | 1 | 2020 | 16 | 0.170 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1163 | 0.170 |
Why?
|
| Male | 14 | 2020 | 43925 | 0.170 |
Why?
|
| Mutagenesis, Insertional | 2 | 2017 | 115 | 0.160 |
Why?
|
| Rhamnose | 1 | 2019 | 4 | 0.160 |
Why?
|
| Borrelia | 2 | 1989 | 3 | 0.160 |
Why?
|
| Metalloendopeptidases | 1 | 2019 | 44 | 0.160 |
Why?
|
| Proteobacteria | 1 | 2019 | 6 | 0.160 |
Why?
|
| Bacterial Vaccines | 4 | 2007 | 44 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 52 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2020 | 207 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2011 | 795 | 0.150 |
Why?
|
| Bacterial Secretion Systems | 1 | 2018 | 10 | 0.150 |
Why?
|
| Ecology | 1 | 2019 | 78 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2019 | 476 | 0.150 |
Why?
|
| Antigens, Surface | 2 | 2001 | 104 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2018 | 21 | 0.150 |
Why?
|
| Escherichia coli Proteins | 1 | 1999 | 184 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2019 | 443 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2019 | 291 | 0.140 |
Why?
|
| Phenotype | 4 | 2007 | 2498 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2020 | 95 | 0.140 |
Why?
|
| Abscess | 3 | 2010 | 95 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 176 | 0.130 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 74 | 0.130 |
Why?
|
| Amino Acid Motifs | 2 | 2021 | 119 | 0.130 |
Why?
|
| In Vitro Techniques | 2 | 2016 | 997 | 0.130 |
Why?
|
| Glycoside Hydrolases | 1 | 2016 | 17 | 0.130 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 39 | 0.130 |
Why?
|
| Chromosomes, Bacterial | 1 | 1996 | 29 | 0.130 |
Why?
|
| Molecular Mimicry | 2 | 2006 | 17 | 0.130 |
Why?
|
| Peptides | 1 | 2019 | 656 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 923 | 0.120 |
Why?
|
| Gene Rearrangement | 1 | 1996 | 176 | 0.120 |
Why?
|
| Perforin | 1 | 2014 | 55 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 561 | 0.110 |
Why?
|
| Female | 10 | 2021 | 47893 | 0.110 |
Why?
|
| Cloning, Molecular | 3 | 2001 | 643 | 0.110 |
Why?
|
| Galactosylceramides | 1 | 2013 | 8 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1477 | 0.100 |
Why?
|
| Lyme Disease | 2 | 1989 | 9 | 0.100 |
Why?
|
| Vaccines, Attenuated | 2 | 2007 | 53 | 0.100 |
Why?
|
| Lipoproteins | 1 | 1993 | 138 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2021 | 358 | 0.100 |
Why?
|
| Virulence | 3 | 2007 | 277 | 0.100 |
Why?
|
| Anaerobiosis | 2 | 2022 | 22 | 0.090 |
Why?
|
| Xylose | 1 | 2011 | 23 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 1399 | 0.090 |
Why?
|
| Open Reading Frames | 2 | 2003 | 120 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 268 | 0.090 |
Why?
|
| NAD | 2 | 2022 | 92 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2016 | 575 | 0.090 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 70 | 0.090 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2010 | 66 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 309 | 0.090 |
Why?
|
| Bacteriological Techniques | 1 | 2010 | 40 | 0.090 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 50 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 2010 | 146 | 0.080 |
Why?
|
| Blotting, Northern | 1 | 2009 | 258 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 542 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2448 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 420 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 46 | 0.080 |
Why?
|
| DNA | 2 | 2024 | 1308 | 0.070 |
Why?
|
| Biological Assay | 1 | 2008 | 81 | 0.070 |
Why?
|
| Binding Sites | 1 | 2010 | 1130 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 283 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 891 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 135 | 0.070 |
Why?
|
| Milk, Human | 1 | 2007 | 46 | 0.070 |
Why?
|
| Tularemia | 1 | 2007 | 8 | 0.070 |
Why?
|
| Francisella tularensis | 1 | 2007 | 9 | 0.070 |
Why?
|
| Chaperonins | 1 | 2006 | 10 | 0.070 |
Why?
|
| Species Specificity | 4 | 1997 | 692 | 0.070 |
Why?
|
| Prevalence | 1 | 2011 | 1294 | 0.070 |
Why?
|
| Immunologic Surveillance | 1 | 2006 | 14 | 0.070 |
Why?
|
| Infant | 2 | 2018 | 3218 | 0.070 |
Why?
|
| Oxygen | 2 | 2022 | 763 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2902 | 0.060 |
Why?
|
| Mothers | 1 | 2007 | 149 | 0.060 |
Why?
|
| Vagina | 1 | 2007 | 176 | 0.060 |
Why?
|
| Natural Killer T-Cells | 2 | 2018 | 46 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 229 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 442 | 0.060 |
Why?
|
| Hydro-Lyases | 1 | 2005 | 6 | 0.060 |
Why?
|
| Guanosine Diphosphate | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cholera Toxin | 2 | 1995 | 21 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 38 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 698 | 0.060 |
Why?
|
| Culture Media | 1 | 2005 | 149 | 0.060 |
Why?
|
| Young Adult | 2 | 2014 | 6624 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2005 | 80 | 0.060 |
Why?
|
| Cytotoxins | 1 | 2024 | 16 | 0.060 |
Why?
|
| Antibodies, Bacterial | 3 | 2007 | 103 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2024 | 44 | 0.060 |
Why?
|
| Complement System Proteins | 1 | 2024 | 83 | 0.060 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2024 | 104 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 319 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 3360 | 0.050 |
Why?
|
| Adult | 3 | 2014 | 27532 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 144 | 0.050 |
Why?
|
| Vitamin K 2 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Quinones | 1 | 2022 | 9 | 0.050 |
Why?
|
| Cytochromes | 1 | 2022 | 58 | 0.050 |
Why?
|
| Fumarates | 1 | 2022 | 20 | 0.050 |
Why?
|
| Electron Transport | 1 | 2022 | 75 | 0.050 |
Why?
|
| Tannerella forsythia | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pedobacter | 1 | 2021 | 1 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2021 | 18 | 0.050 |
Why?
|
| Antigenic Variation | 1 | 2001 | 28 | 0.050 |
Why?
|
| Cholera | 3 | 1997 | 6 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2021 | 22 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2007 | 2517 | 0.040 |
Why?
|
| Respiration | 1 | 2022 | 269 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 202 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2020 | 21 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2020 | 4 | 0.040 |
Why?
|
| Geography | 1 | 2021 | 234 | 0.040 |
Why?
|
| Quinone Reductases | 1 | 2020 | 2 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2020 | 22 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2020 | 26 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 376 | 0.040 |
Why?
|
| Carbohydrate Epimerases | 1 | 1999 | 4 | 0.040 |
Why?
|
| Microfluidics | 1 | 2020 | 55 | 0.040 |
Why?
|
| Prevotella | 1 | 2019 | 3 | 0.040 |
Why?
|
| Vaginosis, Bacterial | 1 | 2019 | 8 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 1999 | 98 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1999 | 26 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2019 | 28 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 211 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 150 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 402 | 0.040 |
Why?
|
| Rats | 3 | 2001 | 4067 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 174 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2003 | 967 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 1025 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 1108 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 1336 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2020 | 614 | 0.030 |
Why?
|
| Racemases and Epimerases | 1 | 1996 | 4 | 0.030 |
Why?
|
| Mannose | 1 | 1996 | 10 | 0.030 |
Why?
|
| Cholera Vaccines | 1 | 1995 | 1 | 0.030 |
Why?
|
| Nucleotides | 1 | 1996 | 98 | 0.030 |
Why?
|
| Rabbits | 2 | 1995 | 644 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 1995 | 68 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 699 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 39 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 241 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1995 | 154 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 268 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 1995 | 202 | 0.030 |
Why?
|
| Aged | 1 | 2011 | 19943 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 2012 | 20 | 0.030 |
Why?
|
| Oligosaccharides | 1 | 2012 | 24 | 0.030 |
Why?
|
| Epitopes | 1 | 1993 | 249 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 259 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1993 | 84 | 0.020 |
Why?
|
| Actins | 1 | 1995 | 470 | 0.020 |
Why?
|
| Middle Aged | 1 | 2011 | 27030 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1991 | 46 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1991 | 36 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3818 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1991 | 161 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1991 | 117 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1991 | 213 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1991 | 196 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 1194 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 509 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1989 | 514 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 78 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2013 | 772 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 775 | 0.020 |
Why?
|
| Endotoxins | 2 | 1995 | 38 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1995 | 3508 | 0.010 |
Why?
|
| Bangladesh | 2 | 1995 | 332 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 9504 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2001 | 41 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 305 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 432 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 501 | 0.010 |
Why?
|
| Serotyping | 1 | 1997 | 28 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 126 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1997 | 277 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1995 | 7 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1995 | 25 | 0.010 |
Why?
|
| Staurosporine | 1 | 1995 | 33 | 0.010 |
Why?
|
| Alkaloids | 1 | 1995 | 46 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1995 | 34 | 0.010 |
Why?
|
| Asia | 1 | 1995 | 102 | 0.010 |
Why?
|
| Permeability | 1 | 1995 | 141 | 0.010 |
Why?
|
| India | 1 | 1995 | 128 | 0.010 |
Why?
|
| Cattle | 1 | 1995 | 380 | 0.010 |
Why?
|
| Ileum | 1 | 1995 | 168 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1995 | 283 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1995 | 277 | 0.010 |
Why?
|
| Africa | 1 | 1994 | 102 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1995 | 673 | 0.010 |
Why?
|
| Swine | 1 | 1995 | 605 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1052 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1995 | 330 | 0.010 |
Why?
|
| Carcinoma | 1 | 1995 | 438 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1939 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 2505 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 583 | 0.010 |
Why?
|